Jefferies Financial Group Upgrades Mettler-Toledo International (NYSE:MTD) to “Hold”

Mettler-Toledo International (NYSE:MTD) was upgraded by analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a report released on Monday, MarketBeat reports. The brokerage presently has a $1,110.00 price objective on the medical instruments supplier’s stock, down from their prior price objective of $1,200.00. Jefferies Financial Group’s price target points to a potential upside of 4.32% from the stock’s current price.

Other research analysts have also recently issued reports about the company. Wells Fargo & Company reduced their price target on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an “equal weight” rating for the company in a research report on Thursday, April 17th. Evercore ISI lifted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. Robert W. Baird decreased their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating for the company in a research note on Tuesday, April 22nd. Finally, Citigroup upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target on the stock in a research report on Monday, April 7th. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $1,296.13.

Mettler-Toledo International Trading Down 2.5 %

Shares of NYSE MTD opened at $1,064.07 on Monday. The company has a 50 day simple moving average of $1,129.03 and a two-hundred day simple moving average of $1,228.33. The stock has a market cap of $22.18 billion, a price-to-earnings ratio of 26.25, a PEG ratio of 3.30 and a beta of 1.40. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.90 by $0.29. The company had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The firm’s quarterly revenue was down 4.6% on a year-over-year basis. During the same period in the previous year, the firm posted $8.89 earnings per share. Analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In related news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Large investors have recently bought and sold shares of the business. Cetera Investment Advisers lifted its stake in Mettler-Toledo International by 14.5% in the 1st quarter. Cetera Investment Advisers now owns 1,231 shares of the medical instruments supplier’s stock worth $1,454,000 after purchasing an additional 156 shares in the last quarter. Legato Capital Management LLC increased its holdings in shares of Mettler-Toledo International by 107.7% in the first quarter. Legato Capital Management LLC now owns 2,050 shares of the medical instruments supplier’s stock valued at $2,421,000 after purchasing an additional 1,063 shares during the last quarter. Venturi Wealth Management LLC lifted its position in Mettler-Toledo International by 92.7% during the first quarter. Venturi Wealth Management LLC now owns 210 shares of the medical instruments supplier’s stock worth $248,000 after buying an additional 101 shares in the last quarter. Oak Thistle LLC boosted its stake in Mettler-Toledo International by 357.2% during the first quarter. Oak Thistle LLC now owns 3,287 shares of the medical instruments supplier’s stock worth $3,882,000 after buying an additional 2,568 shares during the last quarter. Finally, Choreo LLC grew its holdings in Mettler-Toledo International by 5.0% in the 1st quarter. Choreo LLC now owns 543 shares of the medical instruments supplier’s stock valued at $641,000 after buying an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.